Literature DB >> 12598768

Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes.

Matthew I Bonaparte1, Edward Barker.   

Abstract

OBJECTIVE: Determine whether natural killer (NK) cells are capable of killing HIV-infected autologous primary T-cell blasts.
DESIGN: The ability of NK cells to kill HIV-infected primary T-cell blasts, whose cell surface major histocompatibility complex (MHC) class I molecules was decreased, was evaluated in a lytic assay.
METHODS: Phytohemagglutinin-treated CD4+ T cells were infected with HIV-1. Infected cells were separated from uninfected cells by removal of CD4+ T cells. The NK cells were isolated from peripheral blood mononuclear cells (PBMC) of the same donor as the CD4+ T cells by immunomagnetic bead separation. The NK cells isolated from PBMC were then used as effector cells and the HIV-infected T-cell blasts were used as target cells in a lytic assay.
RESULTS: It was demonstrated that HIV infection of primary CD4+ T cells results in a 61-68% reduction in surface expression of MHC class I molecules. Despite the decreased MHC class I expression the NK cells were incapable of lysing autologous HIV-infected T-cell blasts, yet were effective in the lysis of the NK cell sensitive cell line, K562. The inability of NK cells to lyse HIV-infected T-cell blasts is not dependent on the strain of HIV used to infected the CD4+ T cell
CONCLUSION: These studies indicate that despite drastic decreases in MHC class I molecule expression, HIV-infected T-cell blasts can evade destruction by autologous NK cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598768     DOI: 10.1097/00002030-200303070-00003

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  28 in total

1.  HIV-1 Vpu disarms natural killer cells.

Authors:  Jonathan Richard; Éric A Cohen
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

2.  Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates.

Authors:  Tram N Q Pham; Jonathan Richard; Francine C A Gerard; Christopher Power; Éric A Cohen
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

3.  Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu.

Authors:  Ankur H Shah; Bharatwaj Sowrirajan; Zachary B Davis; Jeffrey P Ward; Edward M Campbell; Vicente Planelles; Edward Barker
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

Review 4.  The innate immune system and HIV pathogenesis.

Authors:  Karla A Eger; Derya Unutmaz
Journal:  Curr HIV/AIDS Rep       Date:  2005-02       Impact factor: 5.071

Review 5.  Role of natural killer cells in HIV pathogenesis.

Authors:  Jeffrey Ward; Edward Barker
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

Review 6.  Evasion from NK cell-mediated immune responses by HIV-1.

Authors:  Stephanie Jost; Marcus Altfeld
Journal:  Microbes Infect       Date:  2012-05-21       Impact factor: 2.700

7.  HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.

Authors:  Jonathan Richard; Sardar Sindhu; Tram N Q Pham; Jean-Philippe Belzile; Eric A Cohen
Journal:  Blood       Date:  2009-12-14       Impact factor: 22.113

8.  Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity.

Authors:  Julian J Lum; David J Schnepple; Zilin Nie; Jaime Sanchez-Dardon; Georgina L Mbisa; Jennifer Mihowich; Nanci Hawley; Shanil Narayan; John E Kim; David H Lynch; Andrew D Badley
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 9.  Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?

Authors:  A Boasso; G M Shearer; C Chougnet
Journal:  J Intern Med       Date:  2009-01       Impact factor: 8.989

Review 10.  Immunogenetics of HIV disease.

Authors:  Maureen P Martin; Mary Carrington
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.